1. Inicio
  2. Findings from Hospital Pablo Tobon Uribe in the Area of Type 2 Diabetes Reported (Dose-Response and Clinical Equivalence of Semaglutide and Tirzepatide for Weight Loss in Type 2 Diabetes: A Model-Based Analysis)

Findings from Hospital Pablo Tobon Uribe in the Area of Type 2 Diabetes Reported (Dose-Response and Clinical Equivalence of Semaglutide and Tirzepatide for Weight Loss in Type 2 Diabetes: A Model-Based Analysis) Prensa y medios

  • Perfil

Perfil

Editorial / medio

  • Clinical Trials Daily

autores

  • http://vivoweb.org/ontology/core#FacultyMember
    Adriana María Alzate Echeverri

fecha de publicación

  • junio 18, 2026